In the original article, we neglected to include the funder the “European Union's Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement, 675610” to Tia Tyrsett Kuo.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
chronotherapeutic, circadian rhythm, chemotherapy, cancer, precision (stratified) medicine
Citation
Kuo TT and Ladurner AG (2020) Corrigendum: Exploiting the Circadian Clock for Improved Cancer Therapy: Perspective From a Cell Biologist. Front. Genet. 11:601. doi: 10.3389/fgene.2020.00601
Received
16 May 2020
Accepted
18 May 2020
Published
19 June 2020
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2020
Updates
Copyright
© 2020 Kuo and Ladurner.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tia Tyrsett Kuo tia.tyrsett@bmc.med.lmu.de
This article was submitted to Epigenomics and Epigenetics, a section of the journal Frontiers in Genetics
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.